In addition to the conventional lymphocyte subsets, other lineages have been identified as NK1.1^+^TCR-α/β^+^ (NK1^+^T) cells, NK cells, and intestinal intraepithelial lymphocytes (IELs). NK1^+^T cells have been recently classified as a lymphocyte subset that shares common features with both NK cells and conventional T cells. This lineage expresses NK markers including NKR-P1, Ly-49, and IL-2Rβ/15Rβ as well as an invariant Vα14J281TCR-α chain in combination with Vβ8, Vβ7, or Vβ2 ([@B1], [@B2]). Expression of these TCRs is required for NK1^+^ T cell development ([@B3], [@B4]). They are positively selected by MHC class I--related CD1 or thymic leukemia (TL) molecules ([@B5]--[@B7]). The majority of TCR-α/β^+^ or TCR-γ/δ^+^ intestinal IEL expresses CD8-α/α homodimers. Both NK1^+^T cells and CD8-α/α^+^ intestinal IELs can develop through either extrathymic or alternative thymic pathways ([@B1], [@B2], [@B8]). Notably, the IL-2Rβ/15Rβ chain is required for the development of NK1^+^T cells, NK cells, and CD8-α/α^+^ intestinal IELs ([@B9], [@B10]), and IL-15 preferentially promotes the proliferation of these lymphocyte subsets ([@B10]--[@B12]).

IFN regulatory factor 1 (IRF-1), an IFN-inducible transcriptional activator, was initially identified as a protein that binds *cis*-acting DNA elements in the IFN-β promoter ([@B13]--[@B15]) and the IFN-stimulated response element of IFN-α/β--stimulated genes ([@B16], [@B17]). Recent studies with IRF-deficient (IRF-1^−/−^) mice demonstrated a reduction of CD8^+^TCR-α/β^+^ cells and decreased MHC class I levels as a consequence of reduced expression of transporter associated with antigen processing 1 (TAP-1) and low molecular weight protein 2 (LMP-2; 18, 19).

Since IRF-1 deficiency has been related to T cell maturation, we examined the development of NK1^+^T cells, NK cells, and IELs in IRF-1^−/−^ mice. Data indicated that these lymphocyte subsets were selectively reduced and IL-15 messenger RNA (mRNA) was barely detectable in IRF-1^−/−^ mice. Therefore, IRF-1 regulates the IL-15 gene that is required for survival and/or expansion of these lymphocyte subsets in vivo.

Materials and Methods {#MaterialsMethods}
=====================

Mice.
-----

Mice deficient in IRF-1 ([@B18]) were backcrossed five times with C57BL/6 mice. Homozygous IRF-1^−/−^ mice were bred and identified by staining blood with anti-CD8 and -CD4 mAb. Wild-type or heterozygous mice were used as controls. All mice were maintained in our animal facility according to institutional guidelines, and experiments were done between 8 and 14 wk of age.

Cell Preparation and Culture.
-----------------------------

Liver mononuclear cells (MNCs) and IELs were prepared as previously described ([@B20]). In some experiments, liver MNCs or IELs obtained from IRF-1^−/−^ mice were cultured with 100 ng/ml mouse IL-15 (provided by Immunex Co., Seattle, WA) for 7 d.

Antibodies and Flow Cytometric Analysis.
----------------------------------------

The following mAb conjugates were purchased from PharMingen (San Diego, CA) and used in this study: M1/69-FITC (anti-HSA), 53-5.8-FITC (anti-CD8β), H57-597-FITC and -PE (anti--TCR-β), TM-β1-PE (anti--IL-2Rβ), GL-3-PE (anti--TCR-δ), 53-6.7-PE (anti-CD8), PK136-PE and -biotin (anti-NK1.1), 1B1-PE (anti-CD1), 27D-biotin (anti--LFA-1), IM7-biotin (anti-CD44), and KJ16-biotin (anti-Vβ8.1,8.2). B22-purified mAb (anti--H-2D^b^) was prepared in our laboratory. Biotinylated mAbs were detected with streptavidin red 670 (GIBCO BRL, Gaithersburg, MD) and purified mAbs were detected with goat anti--mouse IgG-FITC or goat anti--rat IgM-FITC; 10^6^ cells were stained in 2% FCS PBS, washed, and analyzed by FACScan^®^ using the Lysis II program (Becton Dickinson, Mountain View, CA).

Analysis for IL-15 mRNA Expression.
-----------------------------------

Bone marrow (BM) cells were isolated and stimulated by 30 μg/ml LPS and 100 U/ml IFN-γ for 6 h. Total cellular RNA was isolated with TRIZOL (GIBCO BRL) according to the manufacturer\'s protocol. 10 μg of total RNA were subjected to electrophoresis in a denaturing 1.0% agarose gel containing 2% formaldehyde and transferred to Hybond N+ nylon membrane (Amersham Corp., Arlington Heights, IL). The filter was hybridized with mouse IL-15 cDNA probe radioactively labeled with \[^32^P\]dCTP. The mouse IL-15 cDNA used as a probe was obtained by polymerase chain reaction using specific primers: sense primer 5′-GCC AGC TCA TCT TCA ACA-3′ and antisense primer 5′-TAA GTC TGA GAC GAG CTC TTT-3′. Radioactivity was assessed using phosphorimager (Molecular Dynamics, Sunnyvale, CA). The filter was stripped and rehybridized with a β-actin cDNA probe.

Results and Discussion {#ResultsDiscussion}
======================

Impaired NK1^+^T Cell and NK Cell Development in IRF-1^−/−^ Mice.
-----------------------------------------------------------------

Mouse NK1^+^T cells are generally either CD4^+^8^−^ or CD4^−^8^−^ cells that are primarily found in the thymus, liver, and BM ([@B1], [@B2]). We examined the NK1^+^T cell subset in mice deficient for IRF-1^−/−^. Surprisingly, the percentages of thymic and liver NK1^+^T cells were decreased by 4--5 fold and 8--10 fold, respectively, in IRF-1^−/−^ mice. The total number of thymic NK1^+^T cells obtained from IRF-1^−/−^ mice was 10-fold lower than in wild-type control mice. Interestingly, a partial reduction of NK1^+^T cells was also seen in IRF-1^+/−^ mice (Fig. [1](#F1){ref-type="fig"}, Table [1](#T1){ref-type="table"}). The IL-2Rβ/15Rβ^+^TCR-α/β^+^ cells were also decreased, suggesting that the pronounced reduction of NK1^+^T cells detected in IRF-1^−/−^ mice was not simply due to the loss of NK1.1 molecules from the cell surface (data not shown). The small number of NK1^+^T cells detected in IRF-1^−/−^ mice expressed the IL-2Rβ/15Rβ chain and preferentially expressed Vβ8^+^ TCR as seen in control mice (data not shown). In addition, analysis of the thymus, liver, and spleen using IRF-1^+/+^, IRF-1^+/−^, and IRF-1^−/−^ mice clearly demonstrated a reduction of NK cells (TCR-β^−^NK1.1^+^) in IRF-1^−/−^ mice (Fig. [1](#F1){ref-type="fig"}). This is consistent with the lack of NK cell function previously reported in IRF-1^−/−^ mice ([@B21]). Interestingly, IRF-1^+/−^ mice consistently showed an intermediate phenotype, reflecting the dose-dependent requirement for genes regulated by IRF-1. These analysis showed that IRF-1 is important for NK cell and NK1^+^T cell development.

Previous reports have shown that CD4^−^8^+^TCRα/β^+^ cells were selectively reduced in thymus and periphery of IRF-1^−/−^ mice ([@B18]). The data demonstrated a crucial role for IRF-1 in T cell development for the first time. A recent paper suggested that IRF-1 controls MHC class I expression through the regulation of transporter associated with antigen 1 and low molecular weight protein ([@B19]). Since mouse NK1^+^T cells require β2-microgloblin--associated CD1 and TL molecules for development ([@B5]--[@B7], [@B20], [@B22], [@B23]), we examined CD1 expression on thymocytes from IRF-1^−/−^ mice. Consistent with a recent paper ([@B19]), Fig. [2](#F2){ref-type="fig"} showed that the lack of the IRF-1 gene clearly resulted in reduced H-2D^b^ expression. However, the mean intensities of CD1 on IRF-1^−/−^ thymocytes was comparable to littermate controls, suggesting that the IRF-1 gene does not control NK1^+^T cell development through CD1 expression. In addition, we can further exclude the role of the TL antigen in NK1^+^T cell development, since both IRF-1^−/−^ and control mice are of the C57B1/6 background and do not express TL.

Maturation of Intestinal IELs Is Reduced in IRF-1^−^ ^/−^ Mice.
---------------------------------------------------------------

The majority of IELs express CD8 and can be divided into two subsets. One population bears CD8-α/β^+^ heterodimers and expresses TCR-α/β^+^, whereas the other expresses CD8-α/α^+^ homodimers consisting of TCR-α/β^+^ and TCR-γ/δ^+^ cells. Using thymectomized recombinase activating gene (RAG)-deficient mice reconstituted with BM cells from athymic (nude) mice, thymus-independent development of CD8-α/α^+^ IELs has been clearly demonstrated to occur ([@B8]). Surprisingly, in IRF-1^−/−^ mice, the percentage of intestinal CD8-α/α^+^ IELs was approximately eight- to ninefold less than in wild-type control mice. As seen with NK1^+^T cells, mice heterozygous for IRF-1^+/−^ showed altered CD8-α/α^+^ IEL development. TCR-γ/δ^+^ IELs were profoundly reduced by IRF gene disruption (Fig. [3](#F3){ref-type="fig"} *A*, Table [2](#T2){ref-type="table"}). In addition, CD8-α/β^+^T cells were also reduced as seen in periphery. The total cell numbers of IELs from IRF-1^−/−^ mice (0.4 ± 0.1 × 10^6^) were three- to fourfold lower than those from littermate controls (1.5 ± 0.3 × 10^6^). Therefore, IRF-1 controls the expression of genes important for IEL T cell development. It is likely that the reduced development of intestinal γ/ δ^+^T cells is controlled by other mechanisms unrelated to MHC class I expression in IRF-1^−/−^ mice. Previous studies using β2-microglobulin--deficient (MHC class I^−/−^) mice showed a reduction in TCR-α/β^+^ IELs, but not TCR-γ/ δ^+^ IELs ([@B24]), demonstrating that TCR-α/β^+^ and TCR-γ/ δ^+^ IELs have differential requirements for β2-microglobulin dependent selection.

Since the majority of thymus-independent intestinal TCR-γ/δ^+^ cells were absent in IRF-1^−/−^ mice, we also examined whether thymic TCR-γ/δ^+^ cells were present in these mice. Although the number of intestinal TCR-γ/δ^+^ cells were decreased by 10-fold in IRF-1^−/−^ mice, thymic TCR-γ/δ^+^ cells were normal (Fig. [3](#F3){ref-type="fig"} *B*, Table [2](#T2){ref-type="table"}). Thus, IRF-1 selectively affected the development of intestinal TCR-γ/δ^+^ cells.

IL-15 mRNA Expression Is Impaired in IRF-1^−^ ^/−^ BM Cells.
------------------------------------------------------------

As certain cytokines are crucial for lymphocyte development, it is possible that a reduction in the expression of cytokine receptors or cytokines may result in poor selection, survival, or expansion of NK1^+^T cells, NK cells, and intestinal IEL subsets in IRF-1^−/−^ mice. IL-15 is one of the most likely targets because NK1^+^T cells, NK cells and intestinal IEL subsets are severely reduced in IL-2Rβ/ 15Rβ^−/−^ mice ([@B9], [@B10]), while present in normal numbers in IL-2, IL-7Rα, or IL-7--deficient mice ([@B10], [@B25]--[@B27]). Interestingly, IL-15 preferentially promotes the proliferation of these T cell subsets ([@B10]--[@B12]). Thus, we examined IL-15 mRNA expression by Northern blot analysis (Fig. [4](#F4){ref-type="fig"} *A*). Wild-type BM cells cultured in the presence of LPS and IFN-γ for 6 h, clearly increased IL-15 mRNA levels. In contrast, IL-15 mRNA remained undetectable in IRF-1^−/−^ BM cells, even after induction with LPS and IFN-γ. These data demonstrate that IRF-1 regulates the expression of IL-15.

NK1^+^T Cells, NK Cells, and Intestinal IELs were Recovered by IL-15 In Vitro.
------------------------------------------------------------------------------

To further examine the importance of IL-15 for maturation of NK1^+^T cells, NK cells, and intestinal IEL subsets in IRF-1^−/−^ mice, liver MNCs and intestinal IELs were isolated from these mice and cultured with 100 ng/ml mouse IL-15 for 7 d (Fig. [4](#F4){ref-type="fig"} *B*). Recovery of these lymphocyte subsets was observed. This suggested that IL-15 is essential for the survival or expansion of NK1^+^T cells, NK cells, and intestinal IELs, and not early development or commitment.

NK1^+^T cells, NK cells, and intestinal IELs share cell surface markers and other common features during development. In addition to the expression and developmental requirement of IL-2Rβ/15Rβ chain, they also express the NK complex that encompasses NKR-P1 and Ly-49 ([@B1], [@B2], [@B28], [@B29]). In contrast, conventional T cells do not express these products. Although the majority of T cells develops in the thymus, NK cells develop normally in athymic nude mice. The developmental origin of NK1^+^T cells can be either thymus dependent or independent ([@B2], [@B30], [@B31]). Thymus-independent development of intestinal CD8-α/α^+^ T cells has been clearly demonstrated to occur ([@B8]). Thus, NK1^+^T cells and intestinal CD8-α/α^+^ T cells are related to the NK lineage and can be distinguished from mainstream T cells. Our results demonstrate that IRF-1 controls the expression of IL-15, which is likely to be important for the maturation of the related NK1^+^T cell, NK cell, and CD8-α/α^+^ IEL lineages.
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![IRF-1 is important for NK1^+^T cell and NK cell maturation. Thymocytes, liver, and spleen MNCs from indicated strains were stained with M1/69-FITC (anti-HSA), H57-597-PE (anti--TCR-β), and PK136-biotin (anti-NK1.1) plus streptavidin 670. HSA^−^ cells are shown.](JEM971185.f1){#F1}

###### 

Impaired Maturation of Thymic NK1^+^T Cells in IRF-1^−^ ^/−^ Mice

  Mice            Total thymocytes (× 10^6^)      HSA^−^ cell      NK1^+^T cell      Total NK1^+^T cell (× 10^4^)
  ------------ -- ---------------------------- -- ------------- -- -------------- -- ------------------------------
                                                  *%*              *%*               
  IRF-1^+/+^      81.7 ± 4.7                      3.4 ± 0.4        11.9 ± 1.4        39.5 ± 8.8
  IRF-1^+/−^      87.3 ± 10.8                     3.2 ± 0.6         8.1 ± 0.6        22.6 ± 7.5
  IRF-1^−/−^      86.0 ± 11.8                     1.6 ± 0.4         2.4 ± 0.4         3.3 ± 0.6

Four to six mice from each group were individually analyzed. Thymocytes were stained with M1/69-FITC (anti-HSA), H57-PE (anti-- TCR-β), and PK136-biotin (anti-NK1.1) plus streptavidin 670. The percentage of NK1^+^T cells was calculated in the HSA^−^ thymocyte population.  

![Normal CD1 expression on IRF-1^−/−^ thymocytes. Thymocytes from the indicated strains were stained with 1B1-FITC (anti-CD1), 57.6.7-PE (anti-CD8), and L3T4-biotin (anti-CD4) plus streptavidin 670, and double-positive CD4^+^8^+^ thymocytes were analyzed for CD1 expression. For H-2D^b^ expression, total thymocytes were stained with B22 (anti--H-2D^b^) plus goat anti--mouse Ig-FITC.](JEM971185.f2){#F2}

![IRF-1 controls intestinal IEL development. (*A*) Intestinal IELs were obtained from either IRF-1^+/+^ mice, IRF-1^+/−^ mice, or IRF-1^−/−^ mice and stained with H57-597 (anti--TCR-β) and GL-3-PE (anti-- TCR-δ), or 53.6.7-FITC (anti--CD8α) and Lyt3-PE (anti-CD8β). (*B*) Thymocytes were stained with L3T4-FITC (anti-CD4), GL-3-PE (anti-- TCR-δ), and 53.6.7-FITC (anti-CD8α). Histograms are gated on double-negative CD4^−^8^−^ thymocytes and TCR-δ expression is shown.](JEM971185.f3){#F3}

###### 

Intestinal and Thymic T Cell Subsets in IRF-1^−^ ^/−^ Mice

  Mice            Intestine       Thymus[\*](#TF2-150){ref-type="table-fn"}                                      
  ------------ -- ------------ -- ------------------------------------------- -- ------------ -- ------------ -- ------------
  IRF-1^+/+^      42.5 ± 4.3       7.5 ± 3.0                                     26.7 ± 2.6      34.7 ± 4.0       9.3 ± 0.5
  IRF-1^+/−^      27.0 ± 2.6      10.5 ± 2.3                                     29.5 ± 3.6      21.0 ± 4.4      10.7 ± 1.8
  IRF-1^−/−^       5.0 ± 3.4       3.2 ± 1.7                                     15.8 ± 8.9       4.6 ± 2.8       9.6 ± 0.8

Four mice in each group were individually analyzed.  

 Total thymocytes were stained with GK1.5-FITC (anti-CD4), GL-3-PE (anti--TCR-γ/δ), and 53.6.7-biotin (anti-CD8) plus streptavidin 670. TCR-γ/δ^+^ cells were analyzed on gated double-negative (CD4^−^8^−^) thymocytes.  

###### 

Impaired lineage development correlates with the absence of IL-15. (*A*) Limited IL-15 expression in the absence of IRF-1. BM cells were isolated from IRF-1^−/−^ mice or control wild-type (*WT*) mice. Total RNA was extracted from untreated BM cells or BM cells cultured for 6 h in the presence of LPS (30 μg/ml) and IFN-γ (100 U/ml). Northern blot analysis was performed using IL-15 cDNA and β-actin probes. (*B*) IL-15 induces the expansion of NK1^+^T cells, NK cells, and IEL subsets. Liver MNCs and intestinal IELs were isolated from IRF-1^−/−^ mice and cultured with 100 ng/ml mouse IL-15 for 7 d.
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